Haleon PLC Logo

Haleon PLC

A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+1 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Haleon PLC is a global leader in consumer healthcare, operating as a pure-play business dedicated to improving everyday health. Formerly the consumer healthcare division of GSK, the company's portfolio comprises a wide range of category-leading, over-the-counter (OTC) brands. Its core product areas include oral health, pain relief, respiratory health, digestive health, and vitamins, minerals, and supplements. Key brands under its management include Sensodyne, Panadol, Advil, Voltaren, and Centrum. With a global presence, Haleon focuses on delivering science-backed and trusted health products directly to consumers worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 11:05
Board/Management Information
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director's Dealing
Director/PDMR Shareholding
English 115.8 KB
2025-09-24 16:00
Major Shareholding Notification
Holding(s) in Company
English 39.0 KB
2025-09-23 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.1 KB
2025-09-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-19 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-18 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-17 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-16 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.0 KB
2025-09-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 18.1 KB
2025-09-11 08:00
Transaction in Own Shares
Transaction in Own Shares
English 17.9 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.